4a6317d1_Afrezza__July_2010__Comment
[#] 3 [Response from NICE-UK] The Committee does not consider the affordability of new technologies, (cost to the PCTs0 but rather their cost effectiveness in terms of how its advice may enable the more efficient use of available healthcare resources [Comment] 
My argument is that long-suffering diabetics should be given the opportunity to use inhaled insulin. The Committee is concerned about longterm safety; however people who have endured injections for almost forty years did not know the long-term safety of their injections when first diagnosed. It is these people who should be offered the opportunity of a respite from the daily pricking regime. Diabetics were paying for needles when drug addicts were given free needles, until the inequality was addressed. It would seem that yet again economic factors are outweighing human compassion and quality of life.
Afrezza: July 2010
Comment